[1] [1] National Cancer Institute, “Skin cancer,” http:// www.cancer.gov/cancertopics/types/skin (2008).

[2] [2] A. Glaessl, A. G. Schreyer, M. B. Wimmershoff, M. Landthaler, S. Feurbach, U. Hohenleutner, “Laser surgical planning with magnetic resonance imaging-based 3-dimensional reconstructions for intralesional Nd:YAG laser therapy of a venous malformation of the neck,” Arch. Dermatol. 137, 1331– 1335 (2001).

[3] [3] C. C. Harland, S. G. Kale, P. Jackson, P. S. Mortimer, J. C. Bamber, “Differentiation of common benign pigmented skin lesions from melanoma by high-resolution ultrasound,” Br. J. Dermatol. 137, 281–289 (2000).

[4] [4] T. Stepinac, C. Felley, P. Jornod, N. Lange, T. Gabrecht, C. Fontolliet, P. Grosjean, G. van Melle, H. van den Bergh, P. Monnier, G. Wagni`eres, G. Dorta, “Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett’s esophagus after oral administration of aminolevulinic acid,” Endoscopy 35, 663–668 (2003).

[5] [5] Y. T. Pan, T. Q. Xie, C. W. Du, S. Bastacky, S. Meyers, M. L. Zeidel, “Enhancing early bladder cancer detection with fluorescence-guided endoscopic optical coherence tomography,” Opt. Lett. 28, 2485– 2487 (2003).

[6] [6] M. Motamedi, R. Johnigan, B. Bell, J. Pasricha, K. Calhoun, “Fluorescence guided optical coherence tomography for early detection of epithelial neoplasia,” Proc. Lasers and Electro-Optics Society 2000 Annual Meeting 1, 151 (2000).

[7] [7] A. Garcia-Uribe, N. Kehtarnavaz, G. Marquez, V. Prieto, M. Duvic, L. V. Wang, “Skin cancer detection by spectroscopic oblique-incidence reflectometry: Classification and physiological origins,” Appl. Opt. 43, 2643–2650 (2004).

[8] [8] T. Yamashita, K. Negishi, T. Hariya, N. Kunizawa, K. Ikuta, M. Yanai, S. Wakamatsu, “Intense pulsed light therapy for superficial pigmented lesions evaluated by reflectance-mode confocal microscopy and optical coherence tomography,” J. Invest. Dermatol. 126, 2281–2286 (2006).

[9] [9] J. Strasswimmer, M. C. Pierce, B. H. Park, V. Neel, J. F. de Boer, “Polarization-sensitive optical coherence tomography of invasive basal cell carcinoma,” J. Biomed. Opt. 9, 292–298 (2004).

[10] [10] G. Yao, L. V. Wang, “Two-dimensional depthresolved Mueller matrix characterization of biological tissue by optical coherence tomography,” Opt. Lett. 24, 537–539 (1999).

[11] [11] S. L. Jiao, M. Todorovi′c, G. Stoica, L. V. Wang, “Fiber-based polarization-sensitive Muellermatrix optical coherence tomography with continuous source polarization modulation,” Appl. Opt. 44, 5463–5467 (2005).

[12] [12] G. J. Tearney, B. E. Bouma, J. G. Fujimoto, “High-speed phase- and group-delay scanning with a grating-based phase control delay line,” Opt. Lett. 22, 1811–1813 (1997).

[13] [13] T. J. Slaga, “SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice,” Environ. Health Persp. 68, 27–32 (1986).

[14] [14] United States National Institutes of Health, “Guide for the care and use of laboratory animals,” US Goverment Printing Office,Washington DC (1985), NIH Publication No. 86–23.

[15] [15] M. E. Brezinski, G. J. Tearney, B. E. Bouma, J. A. Izatt, M. R. Hee, E. A. Swanson, J. F. Southern, J. G. Fujimoto, “Optical coherence tomography for optical biopsy: Properties and demonstration of vascular pathology,” Circ. Am. Heart Assoc. 93, 1206– 1213 (1996).

[16] [16] T. J. Slaga, J. DiGiovanni, L. D. Winberg, I. V. Budunova, “Skin carcinogenesis: Characteristics, mechanisms, and prevention,” in Growth Factors and Tumor Promotion: Implications for Risk Assessment, R. M. McClain, T. J. Slaga, R. LeBoeuf, H. Pitot, Eds., pp. 1–20,Wiley-Liss (1993).